The Hospital of Central Connecticut at New Britain General and Bradley

The Hospital of Central Connecticut at New Britain General and Bradley was paid $220.10M by Medicaid between Jan 2018 and Dec 2024, across 608 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.

33Billing provider infoTHE HOSPITAL OF CENTRAL CONNECTICUT AT NEW BRITAIN GENERAL AND BRADLEY
NEW BRITAIN, CT 06052

33aNPI1053477075assigned 12/28/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$220.10M

24GClaims4,101,984

24DCodes billed608

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Connecticut

Rank by total paid#3 of 18

Median peer was paid$15.60M

This provider vs. median14×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	554,057	$26.74M
2019	553,808	$28.79M
2020	475,147	$24.90M
2021	598,585	$32.17M
2022	636,600	$33.89M
2023	678,256	$38.32M
2024incomplete	605,531	$35.30M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	16%	120,262	102,878	$35.78M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	15%	76,084	63,571	$33.51M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	11%	116,651	102,584	$25.02M
J9271	Injection, pembrolizumab, 1 mg	4.7%	2,181	1,456	$10.45M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	4.4%	118,957	92,791	$9.60M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	4.2%	60,302	51,113	$9.23M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.2%	131,442	37,532	$7.09M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.7%	20,689	18,668	$3.80M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.4%	17,414	8,464	$3.10M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	1.4%	4,860	4,417	$3.02M
96361	Intravenous infusion, hydration; each additional hour	1.3%	53,691	42,300	$2.85M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.2%	21,781	15,303	$2.73M

596 more codes

J1439	Injection, ferric carboxymaltose, 1 mg	1.2%	5,174	$2.69M
70450	Computed tomography, head or brain; without contrast material	1.2%	22,694	$2.66M
71046	Radiologic examination, chest; 2 views	1.1%	42,953	$2.43M
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	1.1%	14,261	$2.37M
59025	Fetal non-stress test	1.0%	13,690	$2.22M
96375	Therapeutic injection; each additional sequential IV push	<1%	48,440	$2.17M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	14,835	$1.98M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	15,356	$1.96M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	2,671	$1.95M
J0897	Injection, denosumab, 1 mg	<1%	2,282	$1.62M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	11,837	$1.60M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	5,413	$1.51M
11043		<1%	5,655	$1.46M
J2357	Injection, omalizumab, 5 mg	<1%	2,424	$1.46M
J9299	Injection, nivolumab, 1 mg	<1%	401	$1.46M
77067	Screening mammography, bilateral, including computer-aided detection	<1%	13,149	$1.40M
99214	Doctor's office visit, returning patient (more involved)	<1%	13,435	$1.32M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	10,047	$1.12M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	5,107	$1.09M
93975		<1%	4,773	$976K
97035		<1%	15,856	$967K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,405	$956K
97010		<1%	33,234	$940K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,835	$927K
S9480	Intensive outpatient psychiatric services, per diem	<1%	9,148	$906K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	14,187	$898K
95811		<1%	1,255	$858K
71045	Radiologic examination, chest; single view	<1%	16,096	$760K
97161		<1%	12,718	$751K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	5,839	$731K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	4,037	$716K
90834	Psychotherapy session, about 45 minutes	<1%	15,708	$706K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,005	$701K
93798		<1%	10,968	$654K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	7,155	$642K
99213	Doctor's office visit, returning patient (routine)	<1%	9,987	$623K
47562		<1%	137	$620K
76830	Ultrasound, transvaginal	<1%	6,072	$612K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	5,936	$603K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,549	$590K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	6,528	$587K
76641		<1%	6,280	$552K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,019	$525K
J2505	Injection, pegfilgrastim, 6 mg	<1%	342	$514K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	1,759	$505K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	95,906	$500K
78815	Positron emission tomography (PET) for limited area imaging	<1%	777	$493K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	31,474	$480K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	6,780	$469K
94060		<1%	2,280	$444K
72141		<1%	1,898	$412K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	20,394	$408K
76770		<1%	4,955	$398K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,570	$388K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,245	$386K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	47,353	$378K
97162		<1%	9,256	$376K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,070	$364K
19083		<1%	318	$350K
90791	Psychiatric diagnostic evaluation	<1%	3,618	$349K
77065	Tomosynthesis, mammo	<1%	3,297	$346K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,060	$338K
77066	Tomosynthesis, mammo	<1%	2,802	$330K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,596	$326K
J0185	Injection, aprepitant, 1 mg	<1%	2,736	$318K
93971		<1%	4,708	$312K
90832	Psychotherapy session, about 30 minutes	<1%	10,135	$304K
10061		<1%	861	$265K
71250		<1%	5,348	$260K
G0390	Trauma response team associated with hospital critical care service	<1%	437	$259K
76536		<1%	3,578	$258K
72110		<1%	6,003	$255K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,259	$247K
62323		<1%	476	$243K
97597		<1%	5,893	$234K
96415		<1%	4,474	$234K
76642		<1%	4,022	$233K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	11,190	$230K
H0015	Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education	<1%	1,871	$225K
Q5114	Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg	<1%	166	$211K
96367		<1%	5,460	$211K
96417		<1%	4,887	$210K
76813		<1%	2,300	$209K
93970		<1%	1,594	$208K
10060		<1%	1,334	$207K
73221		<1%	1,115	$203K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	6,503	$202K
77334		<1%	601	$200K
73564		<1%	8,089	$184K
36430		<1%	1,040	$175K
77063	Screening digital breast tomosynthesis, bilateral	<1%	12,104	$172K
97165		<1%	2,508	$169K
86900		<1%	14,908	$166K
97014		<1%	3,347	$165K
58661		<1%	29	$159K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	4,636	$158K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	<1%	898	$158K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	28	$150K
70491		<1%	910	$142K
72050		<1%	2,385	$141K
99215	Doctor's office visit, returning patient (complex)	<1%	993	$136K
77336		<1%	2,297	$136K
77080		<1%	1,552	$135K
76801		<1%	1,320	$134K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	76,240	$134K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	5,055	$133K
72125	Computed tomography, cervical spine; without contrast material	<1%	8,828	$131K
70496		<1%	745	$107K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	2,786	$105K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	1,223	$102K
71271		<1%	1,023	$100K
93017		<1%	2,344	$92K
97166		<1%	1,822	$91K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	10,809	$90K
76825		<1%	189	$89K
73030		<1%	6,839	$87K
96411		<1%	1,472	$78K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	59	$78K
97535	Self-care/home management training, each 15 minutes	<1%	3,593	$77K
0001A		<1%	2,316	$76K
72100		<1%	1,783	$75K
73630		<1%	7,136	$74K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	110	$74K
0002A		<1%	2,142	$73K
72131		<1%	1,671	$72K
77300		<1%	404	$69K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	355	$68K
74183		<1%	222	$66K
J9306	Injection, pertuzumab, 1 mg	<1%	18	$65K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	1,935	$65K
73130		<1%	6,416	$60K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	539	$58K
74018		<1%	3,411	$58K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,632	$58K
72070		<1%	1,566	$57K
98967		<1%	3,043	$56K
J0882	Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)	<1%	393	$56K
73610		<1%	7,284	$54K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	5,485	$53K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	5,464	$53K
73110		<1%	4,813	$51K
76882		<1%	802	$50K
70486		<1%	2,598	$50K
73700		<1%	1,082	$48K
74174		<1%	288	$48K
77386		<1%	295	$47K
73502		<1%	4,029	$47K
77412		<1%	410	$46K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	1,000	$44K
95806		<1%	451	$44K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	85	$43K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	411	$42K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	78	$41K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	591	$40K
97116		<1%	2,859	$40K
90674		<1%	2,022	$38K
72158		<1%	122	$38K
52356		<1%	18	$36K
78431		<1%	58	$34K
76870		<1%	1,287	$34K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	108	$34K
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	<1%	1,316	$29K
72040		<1%	906	$27K
L4360	Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	301	$25K
74178		<1%	144	$24K
36591		<1%	2,127	$24K
93270		<1%	1,575	$24K
72197		<1%	67	$24K
94660		<1%	704	$23K
98968		<1%	1,027	$23K
73562		<1%	1,426	$23K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	64	$23K
74019		<1%	1,007	$22K
93225		<1%	432	$22K
64721		<1%	26	$22K
80053	Comprehensive metabolic panel	<1%	151,399	$21K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	184,933	$20K
73080		<1%	2,322	$19K
73140		<1%	2,717	$19K
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	558	$18K
78451		<1%	29	$18K
97164		<1%	1,005	$18K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	19,495	$18K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	18	$17K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	52	$17K
88342		<1%	3,632	$17K
36561		<1%	16	$17K
J9155	Injection, degarelix, 1 mg	<1%	150	$17K
72114		<1%	209	$17K
96402		<1%	1,662	$17K
L3809	Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type	<1%	237	$17K
93880		<1%	189	$16K
92610		<1%	203	$16K
90675		<1%	76	$15K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	11,163	$15K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	11,264	$14K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	208	$14K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	90	$14K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	39	$13K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	56	$13K
10005		<1%	30	$12K
64483		<1%	13	$12K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,567	$11K
90732		<1%	152	$11K
96409		<1%	112	$10K
73590		<1%	1,930	$10K
L3807	Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	832	$10K
77290		<1%	70	$10K
76970		<1%	131	$10K
93923		<1%	156	$9K
20553		<1%	42	$9K
20550		<1%	46	$8K
99204	Doctor's office visit, new patient (more involved)	<1%	45	$8K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	218	$8K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	4,071	$7K
J9070	Cyclophosphamide, 100 mg	<1%	57	$7K
72156		<1%	44	$7K
80061	Lipid panel	<1%	1,093	$7K
H0035	Mental health partial hospitalization, treatment, less than 24 hours	<1%	54	$7K
95910		<1%	30	$7K
73090		<1%	1,390	$6K
C9463	Injection, aprepitant, 1 mg	<1%	110	$6K
93308		<1%	44	$6K
83880		<1%	10,218	$6K
71100		<1%	1,592	$5K
90686		<1%	318	$5K
94726		<1%	1,695	$5K
72170		<1%	847	$5K
73560		<1%	351	$5K
78306		<1%	31	$5K
81025		<1%	45,755	$5K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	50	$4K
82728		<1%	4,323	$4K
74240		<1%	27	$4K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	14,452	$4K
83036	Hemoglobin; glycosylated (A1C)	<1%	5,990	$4K
0064A		<1%	96	$3K
73552		<1%	635	$3K
70498		<1%	754	$3K
86923		<1%	457	$3K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	11,345	$3K
83735		<1%	123,473	$3K
0004A		<1%	83	$3K
73060		<1%	633	$3K
73120		<1%	58	$3K
36415	Collection of venous blood by venipuncture	<1%	66,814	$3K
81002		<1%	8,669	$3K
82962		<1%	50,390	$3K
95909		<1%	13	$3K
83550		<1%	4,182	$3K
97163		<1%	59	$3K
0031A		<1%	70	$2K
80048	Basic metabolic panel (calcium, ionized)	<1%	24,691	$2K
0124A		<1%	85	$2K
90677		<1%	16	$2K
72192		<1%	56	$2K
85610		<1%	14,484	$2K
86780		<1%	219	$2K
97602		<1%	312	$2K
76857		<1%	25	$2K
83540		<1%	4,215	$2K
72128		<1%	24	$2K
84443	Thyroid stimulating hormone (TSH)	<1%	6,325	$2K
71101		<1%	374	$2K
73660		<1%	305	$2K
97760		<1%	92	$2K
74420		<1%	75	$2K
J1750	Injection, iron dextran, 50 mg	<1%	26	$2K
J2359	Injection, olanzapine, 0.5 mg	<1%	277	$2K
95816		<1%	14	$2K
12001		<1%	2,421	$2K
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	<1%	14	$2K
29515		<1%	12	$1K
74230		<1%	27	$1K
88307		<1%	1,619	$1K
0054A		<1%	44	$1K
90694		<1%	57	$1K
84702		<1%	6,715	$1K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	406	$1K
82330		<1%	1,690	$1K
12002		<1%	1,106	$1K
0011A		<1%	68	$1K
96523		<1%	177	$1K
83615		<1%	4,284	$1K
82607		<1%	1,538	$1K
J2997	Injection, alteplase recombinant, 1 mg	<1%	14	$1K
72146		<1%	15	$970.05
0012A		<1%	55	$969.00
83690		<1%	57,842	$955.84
87640		<1%	650	$949.59
87641		<1%	445	$910.77
70490		<1%	13	$890.16
88360		<1%	620	$878.31
87086	Culture, bacterial; quantitative colony count, urine	<1%	17,231	$850.76
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	5,138	$838.49
86850		<1%	13,394	$799.55
73100		<1%	65	$777.85
12011		<1%	1,346	$748.69
82784		<1%	749	$683.98
85730		<1%	4,484	$665.40
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	56	$652.12
0072A		<1%	16	$600.00
0071A		<1%	16	$600.00
84484		<1%	55,177	$590.51
86901		<1%	14,952	$522.50
85379		<1%	7,640	$509.53
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	4,736	$509.18
88304		<1%	2,233	$505.72
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,438	$481.95
93242		<1%	15	$466.29
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	13,696	$442.66
87077		<1%	7,978	$441.61
87507		<1%	45	$398.02
81003		<1%	41,252	$387.49
83605		<1%	18,514	$383.30
82803		<1%	3,074	$382.93
82746		<1%	556	$363.97
82378		<1%	621	$347.53
80076		<1%	2,636	$342.94
82947		<1%	419	$336.22
90715		<1%	4,822	$307.53
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	154	$300.44
85045		<1%	1,335	$271.22
84165		<1%	641	$264.28
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	2,245	$259.95
85027		<1%	3,934	$259.53
86140		<1%	2,018	$237.12
96401		<1%	81	$236.28
84703		<1%	6,047	$232.54
36600		<1%	677	$229.85
C2617	Stent, non-coronary, temporary, without delivery system	<1%	350	$229.46
29125		<1%	1,004	$223.32
87186		<1%	6,404	$218.24
84439		<1%	1,421	$205.99
C1769	Guide wire	<1%	3,013	$178.00
81001		<1%	16,677	$175.10
87040		<1%	12,418	$173.24
83521		<1%	535	$173.04
97799		<1%	58	$160.00
82565		<1%	2,156	$154.23
85652		<1%	3,244	$150.84
80143		<1%	1,095	$147.86
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	33,746	$147.61
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	103	$142.35
G0378	Hospital observation service, per hour	<1%	13,136	$129.71
93246		<1%	19	$127.17
87070		<1%	3,297	$126.06
51702		<1%	27	$118.19
82010		<1%	2,915	$118.13
84100		<1%	4,801	$108.57
82570		<1%	720	$107.16
J7030	Infusion, normal saline solution , 1000 cc	<1%	76,318	$102.90
76820		<1%	209	$101.00
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	34	$92.94
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	28	$90.00
73000		<1%	17	$87.79
87088		<1%	2,326	$85.76
L3808	Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment	<1%	590	$83.01
82247		<1%	19	$81.43
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,147	$81.26
82077		<1%	2,907	$80.03
73070		<1%	12	$78.38
84132		<1%	3,121	$74.63
87205		<1%	3,639	$72.32
84156		<1%	546	$70.10
84134		<1%	137	$69.60
82550		<1%	8,669	$62.62
82533		<1%	145	$62.28
87081		<1%	1,160	$57.06
87184		<1%	555	$55.86
87400		<1%	1,418	$55.64
84550		<1%	1,113	$54.63
84152		<1%	214	$52.68
85018		<1%	2,081	$51.98
84155		<1%	179	$51.29
86592		<1%	12	$48.84
82375		<1%	742	$47.08
J7120	Ringers lactate infusion, up to 1000 cc	<1%	33,169	$43.50
82553		<1%	2,694	$42.66
87807		<1%	195	$41.32
82150		<1%	1,418	$39.66
83883		<1%	101	$38.94
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,565	$36.83
96376		<1%	11,743	$34.01
J1836	Injection, metronidazole, 10 mg	<1%	708	$27.27
86803		<1%	29	$27.26
90714		<1%	1,533	$27.19
J2270	Injection, morphine sulfate, up to 10 mg	<1%	7,953	$27.16
94644		<1%	1,047	$26.99
J1170	Injection, hydromorphone, up to 4 mg	<1%	15,494	$25.28
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,738	$24.98
90472	Immunization administration, each additional vaccine (list separately)	<1%	217	$24.89
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	34,488	$22.50
99406		<1%	13	$22.34
83050		<1%	640	$21.12
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	44,878	$18.22
87075		<1%	824	$18.08
J2704	Injection, propofol, 10 mg	<1%	25,517	$17.46
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	26,929	$17.07
80179		<1%	1,066	$16.44
J1790	Injection, droperidol, up to 5 mg	<1%	2,638	$15.16
82374		<1%	678	$14.01
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	2,844	$13.65
85014		<1%	711	$13.56
80164		<1%	206	$12.94
82435		<1%	658	$11.88
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,223	$11.56
J7510	Prednisolone oral, per 5 mg	<1%	160	$11.03
G0008	Administration of influenza virus vaccine	<1%	1,850	$10.04
82310		<1%	304	$9.86
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	699	$9.03
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	18,870	$7.16
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	10,054	$5.58
84075		<1%	258	$4.85
82040		<1%	203	$4.35
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	844	$3.55
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	11,277	$3.48
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,799	$3.39
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	816	$3.34
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	11,150	$3.29
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	8,143	$3.03
82248		<1%	21	$2.85
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	270	$2.44
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	8,848	$2.41
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	20,467	$2.21
J8540	Dexamethasone, oral, 0.25 mg	<1%	9,421	$2.00
J3480	Injection, potassium chloride, per 2 meq	<1%	3,506	$1.70
J2060	Injection, lorazepam, 2 mg	<1%	6,354	$1.67
J1630	Injection, haloperidol, up to 5 mg	<1%	3,238	$1.66
J3475	Injection, magnesium sulfate, per 500 mg	<1%	6,240	$1.20
J0690	Injection, cefazolin sodium, 500 mg	<1%	11,667	$0.88
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	230	$0.62
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	216	$0.57
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	19,264	$0.41
J1644	Injection, heparin sodium, per 1000 units	<1%	6,519	$0.34
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	50	$0.24
84520		<1%	1,114	$0.18
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	39	$0.16
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	<1%	87	$0.09
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	86	$0.09
Q0222	Injection, bebtelovimab, 175 mg	<1%	68	$0.03
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	8,079	$0.02
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	<1%	130	$0.02
36416		0%	443	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	976	$0.00
J1815	Injection, insulin, per 5 units	0%	9,205	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	682	$0.00
A9585	Injection, gadobutrol, 0.1 ml	0%	6,496	$0.00
J9045	Injection, carboplatin, 50 mg	0%	1,734	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	2,816	$0.00
J7050	Infusion, normal saline solution, 250 cc	0%	24,771	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	2,481	$0.00
J7042	5% dextrose/normal saline (500 ml = 1 unit)	0%	428	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	184	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	3,257	$0.00
96368		0%	2,251	$0.00
86706		0%	76	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	1,804	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	6,714	$0.00
V2632	Posterior chamber intraocular lens	0%	78	$0.00
87147		0%	641	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	134	$0.00
88341		0%	1,823	$0.00
A4648	Tissue marker, implantable, any type, each	0%	1,388	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	256	$0.00
G0009	Administration of pneumococcal vaccine	0%	247	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	903	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	4,197	$0.00
95886		0%	617	$0.00
J0131	Injection, acetaminophen, not otherwise specified,10 mg	0%	157	$0.00
91305		0%	132	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	371	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	147	$0.00
83930		0%	126	$0.00
87015		0%	106	$0.00
11046		0%	704	$0.00
87340		0%	264	$0.00
J3490	Unclassified drugs	0%	433,366	$0.00
A6197	Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	0%	92	$0.00
89060		0%	60	$0.00
C1781	Mesh (implantable)	0%	198	$0.00
99153	Mod sedat endo service >5yrs	0%	593	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	462	$0.00
84480		0%	37	$0.00
11045		0%	3,217	$0.00
29130		0%	14	$0.00
91307		0%	32	$0.00
A6214	Foam dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing	0%	363	$0.00
A6213	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing	0%	42	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	68	$0.00
A6022	Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each	0%	110	$0.00
96377		0%	131	$0.00
99292		0%	28	$0.00
86308		0%	230	$0.00
88300		0%	34	$0.00
51798		0%	29	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	228	$0.00
91306		0%	96	$0.00
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	0%	440	$0.00
A4217	Sterile water/saline, 500 ml	0%	696	$0.00
36410		0%	15	$0.00
91303		0%	70	$0.00
76377		0%	27	$0.00
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	0%	36	$0.00
J0697	Injection, sterile cefuroxime sodium, per 750 mg	0%	276	$0.00
J3535	Drug administered through a metered dose inhaler	0%	183	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	33	$0.00
91301		0%	140	$0.00
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	17	$0.00
77001		0%	27	$0.00
86704		0%	21	$0.00
90839		0%	203	$0.00
J0456	Injection, azithromycin, 500 mg	0%	30	$0.00
Q0247	Injection, sotrovimab, 500 mg	0%	62	$0.00
87493		0%	12	$0.00
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	0%	58	$0.00
86880		0%	17	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	613	$0.00
J2360	Injection, orphenadrine citrate, up to 60 mg	0%	13	$0.00
99152		0%	1,900	$0.00
94729		0%	2,270	$0.00
83970		0%	93	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	558	$0.00
76376		0%	1,810	$0.00
76827		0%	173	$0.00
93325		0%	303	$0.00
94645		0%	41	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	6,051	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	2,122	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	3,835	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	761	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	928	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	1,372	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	2,243	$0.00
J0640	Injection, leucovorin calcium, per 50 mg	0%	2,155	$0.00
98966		0%	151	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	535	$0.00
84295		0%	950	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	107	$0.00
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	0%	12	$0.00
86618		0%	274	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	682	$0.00
Q0244	Injection, casirivimab and imdevimab, 1200 mg	0%	43	$0.00
C1729	Catheter, drainage	0%	725	$0.00
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	0%	104	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	1,256	$0.00
93356		0%	1,744	$0.00
84450		0%	454	$0.00
J9263	Injection, oxaliplatin, 0.5 mg	0%	516	$0.00
88173		0%	550	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	730	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	2,001	$0.00
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	0%	64	$0.00
88312		0%	245	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	250	$0.00
86334		0%	29	$0.00
97598		0%	192	$0.00
88313		0%	14	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	160	$0.00
77012		0%	36	$0.00
A6210	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing	0%	23	$0.00
90750		0%	36	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	96	$0.00
94727		0%	136	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	212	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	338	$0.00
77002		0%	84	$0.00
C1758	Catheter, ureteral	0%	147	$0.00
84460		0%	345	$0.00
88112		0%	55	$0.00
88302		0%	46	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	515	$0.00
76937		0%	57	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	150	$0.00
91300		0%	4,467	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	477	$0.00
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	0%	260	$0.00
J9060	Injection, cisplatin, powder or solution, 10 mg	0%	27	$0.00
91312		0%	66	$0.00
Q0169	Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	27	$0.00
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	0%	173	$0.00
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	0%	15	$0.00
31720		0%	17	$0.00
78434		0%	14	$0.00
C1788	Port, indwelling (implantable)	0%	15	$0.00
86922		0%	16	$0.00
82140		0%	13	$0.00
76942		0%	29	$0.00
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	0%	67	$0.00
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	0%	32	$0.00
90653		0%	34	$0.00
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	0%	20	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	15	$0.00
90840		0%	24	$0.00
J9171	Injection, docetaxel, 1 mg	0%	13	$0.00
76098		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHAVICAN, GARY (PRESIDENT)

Same official

Other billing entities under HAVICAN, GARY

Full network →

Provider	Location	Paid
Hunter's Ambulance Service, INC.	Meriden, CT	$25.52M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.